Goodman Continues On Rising Star Arc As FDA’s Chief Medical Officer
This article was originally published in The Tan Sheet
Jesse Goodman has become FDA's acting chief medical officer and is the agency's lone representtative on the Federal Coordinating Committee on Comparative Effectiveness Research
You may also be interested in...
FDA's top leadership team will not split duties along food and medical products, sources close to the selection process say
The White House is set to nominate former New York City Health Commissioner Margaret Hamburg as FDA commissioner, according to sources knowledgeable about the selection process
Questions swirling around the $1.1 billion in comparative effectiveness research funding should be answered by July 30, the due date for a report to Congress with details of how the money provided in the economic stimulus package for the research will be spent